CXCL12 and leukemia: When CXCL12 was supplemented in the lower chamber of the transwell device, leukemia cells were enhanced to migrate into the chamber (set as 100% as control), and E5 significantly inhibited this effect in all cell lines tested in a concentration-dependent manner.